Diabetes and COVID-19: What 2 Years of the Pandemic Has Taught Us.

Stoian, Anca Pantea; Kempler, Peter; Stulnig, Thomas; Rizvi, Ali A; Rizzo, Manfredi

Stoian, Anca Pantea; Kempler, Peter; Stulnig, Thomas; Rizvi, Ali A; Rizzo, Manfredi.

Affiliation

Stoian AP; Department of Diabetes, Nutrition and Metabolic Diseases, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Kempler P; National Institute of Diabetes, Nutrition and Metabolic Diseases "Prof N.C. Paulescu," Bucharest, Romania.
Stulnig T; Department of Medicine and Oncology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Rizvi AA; Department of Medicine III and Karl Landsteiner institute for Metabolic Diseases and Nephrology, Clinic Hietzing, Vienna Healthcare Group, Vienna, Austria.
Rizzo M; Department of Medicine, University of Central Florida College of Medicine, Orlando, Florida, USA.

Metab Syndr Relat Disord ; 20(3): 137-140, 2022 04.

Article de En | MEDLINE | ID: mdl-34967689

Sujet(s)
Mots clés

COVID-19; cardiometabolic risk; complications; diabetes; obesity; treatment

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète / COVID-19 Limites: Humans Langue: En Journal: Metab Syndr Relat Disord Sujet du journal: METABOLISMO Année: 2022 Type de document: Article Pays d'affiliation: Roumanie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google